Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

Abroad (travel likely)RecruitingPHASE2

Conditions

Mouth Neoplasms · Carcinoma, Squamous Cell

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Lai-ping Zhong, PhD, MD, DDS) · zhonglaiping@163.com · +86-21-23271699

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy

Carcinoma · Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Fullerton, United States · Los Angeles, United States

Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy

Cancer · Neoplasms

Abroad (travel likely)Recruiting

Irvine, United States · Newport Beach, United States